NEWS
Our Latest News
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
ARCHIMED initiates the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control transactions, including public tenders.
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
September
11,
2024
ARCHIMED acquires Irrimax, market leader in anti-microbial wound irrigation solutions
August
28,
2024
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
April
9,
2024
368